It’s been a slog for biotech stocks in 2024. But that shouldn’t necessarily be the case, as artificial intelligence (AI) has created limitless potential in the market.
The medical industry is on the cusp of revolutionary breakthroughs in therapies and general patient care… beyond what you hear on the news about popular weight loss drugs.
AI and machine learning can help doctors analyze medical imaging data (think X-rays and MRIs) to diagnose patients quickly and accurately.
However, AI’s most significant revolution has come in the biotechnology industry.
This post appeared first on Money & Markets, LLC.